PCI Synthesis is a prominent supplier to the pharmaceutical industry, specialising in comprehensive services which support the development and manufacture of pharmaceutical products. The company offers a wide range of solutions designed to meet the rigorous demands of their clients, focusing on the synthesis and production of active pharmaceutical ingredients (APIs) and generics. With a commitment to quality and regulatory compliance, PCI Synthesis plays a crucial role in the contract development and manufacturing organisation (CDMO) space, providing essential support throughout the product lifecycle, from early-stage research and development to full-scale manufacturing.

Services include:
- Analytical Services
- cGMP Synthesis
- Chemistry (CMC)
- Manufacturing
- Contract Development and Manufacturing (CDMO)
- APIs (Active Pharmaceutical Ingredients)
- Generics
- Micronization
- Organic Synthesis
- Process Development
- Process R&D
- Process Validation Studies
- Quality QA/QC
- R&D Services
- Stability
- ICH
- Regulatory Services

PCI Synthesis is dedicated to delivering high-quality services tailored to the needs of the pharmaceutical industry, ensuring that clients receive exceptional support in their projects. For further details, please visit pcisynthesis.com.